Study on the effectiveness of transfusion program in dengue patients receiving platelet transfusion
Journal Title: International Journal of Blood Transfusion and Immunohematology - Year 2012, Vol 2, Issue 2
Abstract
Aims: Dengue infection is a global health problem affecting an estimated population of 50–100 millions every year. Thrombocytopenia is an essential diagnostic criteria. Platelet transfusion is given in those patients who have haemorrhagic manifestations along with thrombocytopenia. The aim of the study was to know the effectiveness of platelet transfusion in dengue patients. Methods: The study was conducted during the epidemic of dengue fever from July 2011 to October 2011. Serologically confirmed dengue cases were included in the study. Results: Two hundred thirty two patients were positive for dengue serological tests of which 195 (84.2%), 35 (15%), 2 (0.8%) were DF, DHF DSS respectively. One hundred eighty two (78.4%) patients received platelet transfusion. One hundred eighteen (51%) cases received single unit of platelet transfusion though platelet count was between 0.2–1.0x10x105/mm3. Sixty four (27.5%) patients who had platelet count <0.2x105/mm3 received multiple platelet transfusions. The patient who received multiple platelet transfusion of 10–12 units showed post transfusion increment of >0.5x105/mm3 and they were discharged after 5–6 days of hospitalization. Conclusions: This study suggests that 51% platelet transfusions are inappropriate and it is more effective when it is given to patients with platelet count <0.2x105/mm3. Platelet transfusion practice should be based upon platelet count and haemorrhagic manifestations as this decreases hospitalization of the patients and complications of dengue.
Authors and Affiliations
Nagarekha Kulkarni
Keywords
Related Articles
- EP ID EP210099
- DOI 10.5348/ijbti-2012-8-OA-3
- Views 102
- Downloads 0
Iron deficiency in regular blood donors in Enugu (Southeastern Nigeria)
Aims: Regular donors are often given some sort of non-monetary recognition. In Nigeria, about 92.9% of individuals donate blood because of the benefits they get from hospital. The aim was to study iron status of regular...
The prevalence of transfusion transmitted infections: A focus on hepatitis B virus among blood donors at Hawassa blood bank center, Southern Ethiopia
Aims: Millions of lives are saved each year through blood transfusion but a safe blood supply is a critical component of health care to prevent the spread of blood-borne infectious diseases. Therefore, it is essential to...
Serosurvey of human T cell lymphotropic virus I/II among blood donors in Gombe (Nigeria)
Aim: This study was carried out to determine the prevalence of human T cell lymphotropic virus I/II (HTLV I/II) among blood donors at the Federal Teaching Hospital Gombe (FTHG), North-eastern, Nigeria. Methods: A total...
Lifetime risk and characterization of red blood cell alloimmunization in chronically transfused patients with sickle cell disease
Aims: Patients with sickle cell disease (SCD) are often exposed to multiple units of blood transfusions predisposing them to the development of alloantibodies. Alloantibodies make subsequent transfusion difficult, costly...
Induced pluripotent stem cells: An update
Introduction: The discovery that the mature cells can be reprogrammed to become pluripotent increased the enormous interest in induced pluripotent stem cell (iPSC) technology for their potential application in biomedical...